Algo version: 0.98b
SRNE is listed at the NASDAQ Exchange
SRNE [SRNE]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is SRNE stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

On Friday 21st of November 2014, Sorrento Therapeutics Inc had a stock price of $3.89. If you invested back then, your return now would be a loss of $-3.89 per share or -99.92%

No, the average daily trading liquidity for Sorrento Therapeutics Inc is $965 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Sorrento Therapeutics Inc has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Sorrento Therapeutics Inc to be medium [0.7 out of 1]